BFC Planning’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
SL
BFC Planning's IRON Position: Q3 2026 in Review
BFC Planning held its Disc Medicine (IRON) position steady in Q3 2026 at 7 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #3298.
BFC Planning first reported a position in IRON in Q3 2025 and has held it in 5 quarters since. The position peaked at $556 in Q4 2025. 150 funds tracked by Wall St. Rank hold IRON as of Q3 2026.
- BFC Planning held 7 shares of Disc Medicine worth $458 as of Q3 2026.
- BFC Planning left its Disc Medicine share count unchanged in Q3 2026.
- Disc Medicine made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3298 holding.
- BFC Planning first reported a position in Disc Medicine in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Disc Medicine position peaked at $556 in Q4 2025.
- 150 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.